Marc O'Connor speaks to Specialty Pharmacy Times editor Davy James at the 2015 Armada Specialty Pharmacy Summit: Aligning Manufacturers, PBMs and Pharmacies
Prove the value of high cost therapies.
30% – Documented adherence improvement among chronically ill patients on Curant’s medication management protocols.
90% – Current HCV 12-week cure rates.
Drive down costs for plan sponsors.
$3000 – Demonstrated savings per patient / per year in overall healthcare costs.
Connecting us all are the patients.
69% – Curant HIV patients whose viral loads improved to undetectable.